Sales rise 3.92% to Rs 135.77 crore
Net Loss of Orchid Pharma reported to Rs 35.60 crore in the quarter ended June 2019 as against net loss of Rs 46.01 crore during the previous quarter ended June 2018. Sales rose 3.92% to Rs 135.77 crore in the quarter ended June 2019 as against Rs 130.65 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales135.77130.65 4 OPM %-6.91-10.91 -PBDT-4.23-23.53 82 PBT-35.60-56.32 37 NP-35.60-46.01 23Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
